Fig. 2From: Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shockCardiovascular support measures over time for angiotensin-II versus placebo. Displays the hourly total vasopressor dose in norepinephrine equivalents and mean arterial pressure over time by treatment group. Black curves show the placebo group. Pink curves show the Ang-II group. Error bars display the SEM. Ang-II angiotensin-II, SEM standard error of the meanBack to article page